Also, there was no significant association between expression of OCT4, SOX2, and NANOG and clinical or pathological data (P>0.05), although slightly higher values were noted in patients without lymph node metastasis. The gene discussed is POU5F1; the disease is metastatic malignant neoplasm in the lymph nodes.